Prior metabolic surgery reduced COVID-19 severity: Systematic analysis from year one of the COVID-19 pandemic

Obesity is a risk factor for COVID-19 severity. Recent studies suggest that prior metabolic surgery (MS) modifies the risk of COVID-19 severity. COVID-19 outcomes were compared between patients with MS (n = 287) and a matched cohort of unoperated patients (n = 861). Multiple logistic regression was...

Full description

Saved in:
Bibliographic Details
Published in:Heliyon 2023-05, Vol.9 (5), p.e15824-e15824, Article e15824
Main Authors: Wood, G. Craig, Benotti, Peter N., Fano, Rodrigo M., Dove, James T., Rolston, David DK, Petrick, Anthony T., Still, Christopher D.
Format: Article
Language:English
Subjects:
COVID-19
COVID-19 infection
death
Metabolic surgery
obesity
Outcomes
Pooled analysis
regression analysis
risk factors
surgery
systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Obesity is a risk factor for COVID-19 severity. Recent studies suggest that prior metabolic surgery (MS) modifies the risk of COVID-19 severity. COVID-19 outcomes were compared between patients with MS (n = 287) and a matched cohort of unoperated patients (n = 861). Multiple logistic regression was used to identify predictors of hospitalization. A systematic literature review and pooled analysis was conducted to provide overall evidence of the influence of prior metabolic surgery on COVID-19 outcomes. COVID-19 patients with MS had less hospitalization (9.8% versus 14.3%, p = 0.049). Age 70+, higher BMI, and low weight regain after MS were associated with more hospitalization after COVID-19. A systematic review of 7 studies confirmed that MS reduced the risk of post-COVID-19 hospitalization (OR = 0.71, 95%CI = [0.61–0.83], p 
ISSN:2405-8440
2405-8440
DOI:10.1016/j.heliyon.2023.e15824